Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy

Selection of patients with pancreatic adenocarcinoma who may benefit from radiotherapy

Abstract Despite combination chemotherapy demonstrating a positive effect on survival, the clinical outcomes of pancreatic adenocarcinoma (PDAC) remain poor. Radiotherapy was previously a component of the curative treatment of PDAC. Advances in imaging and computer sciences have enabled the prescrip...

Full description

Bibliographic Details
Main Authors: I-Shiow Jan, Hui Ju Ch’ang
Format: Article
Language:English
Published: BMC 2023-08-01
Series:Radiation Oncology
Subjects:
Pancreatic adenocarcinoma
Radiotherapy
Biomarker
Radiomic
Online Access:https://doi.org/10.1186/s13014-023-02328-y

Similar Items

Similar Items